Germany's Synlab agrees to sell vet business to Mars
Aug 14 (Reuters) - German medical diagnostics provider
Synlab SYAB.DE on Monday said it has agreed to sell its
veterinary business to the privately owned U.S. confectionary
and pet food giant Mars Inc.
Synlab has not revealed the deal's value but said the vet
branch has accounted for less than 1% of total group revenue in
2022.
(Reporting by Andrey Sychev
Editing by Miranda Murray)
((Andrey.Sychev2@thomsonreuters.com; Twitter: https://twitter.com/sich_11;))
Recent news on Synlab AG
See all newsUK's NHS says hackers have published data stolen in ransomware attack (updated)
Brief: Synlab Says Cybersecurity Incident At Synnovis In UK
Diagnostics provider Synlab signs delisting agreement with Ephios
Brief: Ephios Bidco To Make Public Delisting Acquisition Offer To Shareholders Of Synlab
Brief: Synlab Continues To Expect AEBITDA Margin To Improve From Its Low Point in 2023